BHSC.CN
BioHarvest Sciences Inc.
1W: -1.9%
1M: -6.5%
3M: -5.4%
1Y: +5.6%
3Y: +3517699114944.2%
5Y: -95.7%
C$7.95
Last traded 2025-02-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market CapC$137.8M ($99.5M)
52W Range0.2-9.2
Volume300
Avg Volume1,105
Beta1.51
Dividend—
Analyst Ratings
Company Info
CEOIlan Sobel
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2015-10-01
Websitebioharvest.com
1140-625 Howe Street
Vancouver, BC V6C 2T6
CA
Vancouver, BC V6C 2T6
CA
604 622 1186
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found